• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tumor-inhibitory effect of a streptococcal preparation (NSC-B116209).

作者信息

Tsukagoshi S, Sakurai Y, Sato H, Akiba T SUZUKI S

出版信息

Cancer Chemother Rep. 1972 Feb;56(1):9-17.

PMID:4337882
Abstract
摘要

相似文献

1
Tumor-inhibitory effect of a streptococcal preparation (NSC-B116209).一种链球菌制剂（NSC-B116209）的肿瘤抑制作用
Cancer Chemother Rep. 1972 Feb;56(1):9-17.
2
[Antitumor activity of adriamycin].[阿霉素的抗肿瘤活性]
Jpn J Antibiot. 1972 Apr;25(2):65-71.
3
[Toxicologic study and experimental antitumor activity of rubidomycin (13,057 R.P.)].[柔红霉素（13,057 R.P.）的毒理学研究及实验抗肿瘤活性]
Pathol Biol. 1967 Oct;15(19):903-8.
4
Antineoplastic action of methylglyoxal.
Neoplasma. 1970;17(1):25-35.
5
[Antineoplastic antibiotics from Streptomycetes].[来自链霉菌的抗肿瘤抗生素]
Arzneimittelforschung. 1970 Mar;20(3):301-16.
6
A new antitumor antibiotic, kidamycin. II. Experimental treatment of cancer with kidamycin.
J Antibiot (Tokyo). 1972 Oct;25(10):553-6. doi: 10.7164/antibiotics.25.553.
7
Anticancer activity of 2-(2-(5-nitro-2-furyl)vinyl)-8-(beta-(N,N-diethylamino)ethoxy)quinoline.2-(2-(5-硝基-2-呋喃基)乙烯基)-8-(β-(N,N-二乙氨基)乙氧基)喹啉的抗癌活性
Chem Pharm Bull (Tokyo). 1974 Oct;22(10):2470-5. doi: 10.1248/cpb.22.2470.
8
[Antineoplastic effective antibiotics from Streptomycetes].[链霉菌产生的抗肿瘤有效抗生素]
Arzneimittelforschung. 1967 Jun;17(6):693-706.
9
Chemotherapeutic properities of anthramycin.氨茴霉素的化疗特性。
Chemotherapy. 1966;11(5):249-60. doi: 10.1159/000220459.
10
Some antineoplastic antibiotics.一些抗肿瘤抗生素。
J Pharm Sci. 1972 Apr;61(4):485-501. doi: 10.1002/jps.2600610402.

引用本文的文献

1
Contemporary Management of Malignant Ascites.恶性腹水的当代管理
J Surg Res. 2025 Mar;307:157-175. doi: 10.1016/j.jss.2025.01.025. Epub 2025 Mar 3.
2
Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei.腹膜假性黏液瘤患者免疫微环境及免疫相关治疗的研究进展。
Cancer Biol Med. 2024 Jul 18;21(7):586-605. doi: 10.20892/j.issn.2095-3941.2024.0109.
3
Exploiting bacterial-origin immunostimulants for improved vaccination and immunotherapy: current insights and future directions.
利用源自细菌的免疫刺激剂改善疫苗接种和免疫治疗：当前见解与未来方向
Cell Biosci. 2024 Feb 17;14(1):24. doi: 10.1186/s13578-024-01207-7.
4
Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion.多机构随机临床研究：腔内化疗单独治疗、免疫治疗单独治疗与免疫化疗治疗恶性胸腔积液的疗效比较
Br J Cancer. 1999 May;80(5-6):775-85. doi: 10.1038/sj.bjc.6690421.
5
Postoperative chemotherapy including intraperitoneal and intradermal administration of the streptococcal preparation OK-432 for patients with gastric cancer and peritoneal dissemination: a prospective randomized study.胃癌伴腹膜播散患者术后化疗：包括腹腔内及皮内注射链球菌制剂OK-432的前瞻性随机研究
Cancer Chemother Pharmacol. 1994;33(5):366-70. doi: 10.1007/BF00686264.
6
Induction of antitumor L3T4-positive T cells by OK-432 at tumor sites in mice.OK-432在小鼠肿瘤部位诱导抗肿瘤L3T4阳性T细胞
Cancer Immunol Immunother. 1993;36(4):245-50. doi: 10.1007/BF01740906.
7
OK432 inhibits experimental hepatic metastasis of colon adenocarcinoma ACL-15 in F344 rats.OK432抑制F344大鼠结肠腺癌ACL-15的实验性肝转移。
Surg Today. 1994;24(8):694-700. doi: 10.1007/BF01636774.
8
Effect of splenectomy on hepatic metastasis of colon carcinoma and natural killer activity in the liver.脾切除术对结肠癌肝转移及肝脏自然杀伤活性的影响。
Dig Dis Sci. 1995 Nov;40(11):2398-406. doi: 10.1007/BF02063244.
9
Pharmacological studies on a plant lectin, Aloctin A. I. Growth inhibition of mouse methylcholanthrene-induced fibrosarcoma (Meth A) in ascites form by Aloctin A.一种植物凝集素Aloctin A的药理学研究。I. Aloctin A对小鼠甲基胆蒽诱导的腹水型纤维肉瘤（Meth A）的生长抑制作用。
Experientia. 1981 Nov 15;37(11):1186-7. doi: 10.1007/BF01989910.
10
Re-evaluation of immunological parameters in immunotherapy for advanced carcinoma of the digestive tract.
Gastroenterol Jpn. 1983 Aug;18(4):377-83. doi: 10.1007/BF02774956.